Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 7, 2026

Oct. 7, 2026

Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development

Indeterminate GlobeNewswire

Oct. 7, 2026

Clearsense Introduces Cloud Medical Image Archive to Reduce Infrastructure and Storage Costs

Indeterminate GlobeNewswire

Oct. 7, 2026

ZeroMe Launches OffsetC App to Bring Transparency and Personal Agency to Carbon Offsetting

Indeterminate GlobeNewswire

Oct. 7, 2026

WillScot Elects Donald Slager to Board of Directors

Indeterminate GlobeNewswire

Oct. 7, 2026

AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy

Indeterminate GlobeNewswire

Oct. 7, 2026

Aptean startet Ascent: eine ergebnisbasierte KI-Partnerschaft, die auf messbaren Geschäftsergebnissen aufbaut

Indeterminate GlobeNewswire

Oct. 7, 2026

Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results

Indeterminate GlobeNewswire

Oct. 7, 2026

Aptean lance Ascent, un partenariat d’IA axé sur les résultats et fondé sur une performance métier mesurable

Indeterminate GlobeNewswire

Oct. 7, 2026

Aptean lanceert Ascent, een AI-partnerschap op basis van meetbare bedrijfsresultaten

Indeterminate GlobeNewswire

Oct. 7, 2026

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness

Indeterminate GlobeNewswire

Oct. 7, 2026

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

Indeterminate GlobeNewswire

Oct. 7, 2026

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Oct. 7, 2026

Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live

Indeterminate GlobeNewswire

Oct. 7, 2026

AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base

Indeterminate GlobeNewswire

Oct. 7, 2026

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum

Indeterminate GlobeNewswire

Oct. 7, 2026

Bitcoin Learns to Move: IBVM Lists on MEXC as TOKEN2049 Comes to Singapore

Indeterminate GlobeNewswire

Oct. 7, 2026

Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference

Indeterminate GlobeNewswire